Literature DB >> 17300294

The peptide hormone xenin induces gallbladder contractions in conscious dogs.

Y Kamiyama1, R Aihara, T Nakabayashi, E Mochiki, T Asao, H Kuwano.   

Abstract

Xenin is a 25-amino acid peptide isolated from human gastric mucosa. The biological activities of xenin include modulating intestinal motility and affecting exocrine pancreatic secretion and gastric acid secretion. The physiological effect of xenin on the gastrointestinal tract, however, is incomplete. The objective of this study is to investigate the effects of xenin on the gastrointestinal tract motility of conscious dogs. Gastrointestinal tract and gallbladder contractions were monitored by chronically implanted force transducers. Synthetic xenin was injected intravenously during the interdigestive state with or without pretreatment with cholinergic blockers. The effects of xenin following cholecystectomy and truncal vagotomy were also investigated. Xenin induced gallbladder and jejunal contractions, although a dose-dependent response was shown only with gallbladder contractions. These effects were inhibited by pretreatment with cholinergic blockers, but were not enhanced by truncal vagotomy. The jejunal contractions were completely inhibited by cholecystectomy. The only direct effect of xenin in terms of gastrointestinal motility was to induce gallbladder contractions in conscious dogs. The neural pathway mediating xenin's action was cholinergic, but not the vagal. This novel finding indicates a new role of xenin.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17300294     DOI: 10.1111/j.1365-2982.2006.00881.x

Source DB:  PubMed          Journal:  Neurogastroenterol Motil        ISSN: 1350-1925            Impact factor:   3.598


  13 in total

1.  Xenin-25 potentiates glucose-dependent insulinotropic polypeptide action via a novel cholinergic relay mechanism.

Authors:  Burton M Wice; Songyan Wang; Dan L Crimmins; Kelly A Diggs-Andrews; Matthew C Althage; Eric L Ford; Hung Tran; Matthew Ohlendorf; Terry A Griest; Qiuling Wang; Simon J Fisher; Jack H Ladenson; Kenneth S Polonsky
Journal:  J Biol Chem       Date:  2010-04-26       Impact factor: 5.157

2.  Nesfatin-1 suppresses gastric contractions and inhibits interdigestive migrating contractions in conscious dogs.

Authors:  Akira Watanabe; Erito Mochiki; Akiharu Kimura; Norimichi Kogure; Mitsuhiro Yanai; Atsushi Ogawa; Yoshitaka Toyomasu; Kyoichi Ogata; Tetsuro Ohno; Hideki Suzuki; Hiroyuki Kuwano
Journal:  Dig Dis Sci       Date:  2015-01-07       Impact factor: 3.199

3.  Xenin-25 delays gastric emptying and reduces postprandial glucose levels in humans with and without type 2 diabetes.

Authors:  Sara Chowdhury; Dominic N Reeds; Dan L Crimmins; Bruce W Patterson; Erin Laciny; Songyan Wang; Hung D Tran; Terry A Griest; David A Rometo; Judit Dunai; Michael J Wallendorf; Jack H Ladenson; Kenneth S Polonsky; Burton M Wice
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2013-12-19       Impact factor: 4.052

4.  Mechanism of gastrointestinal abnormal motor activity induced by cisplatin in conscious dogs.

Authors:  Hiroyuki Ando; Erito Mochiki; Tetsuro Ohno; Mitsuhiro Yanai; Yoshitaka Toyomasu; Kyoichi Ogata; Yuichi Tabe; Ryuusuke Aihara; Toshihiro Nakabayashi; Takayuki Asao; Hiroyuki Kuwano
Journal:  World J Gastroenterol       Date:  2014-11-14       Impact factor: 5.742

5.  The effect of growth hormone releasing peptide-2 on upper gastrointestinal contractile activity and food intake in conscious dogs.

Authors:  Katsuyoshi Kudoh; Chikashi Shibata; Yuji Funayama; Kouhei Fukushima; Tatsuya Ueno; Keiichi Hayashi; Akio Inui; Cyril Y Bowers; Iwao Sasaki
Journal:  J Gastroenterol       Date:  2009-03-07       Impact factor: 7.527

6.  Metabolic responses to xenin-25 are altered in humans with Roux-en-Y gastric bypass surgery.

Authors:  Karin Sterl; Songyan Wang; Lauren Oestricker; Michael J Wallendorf; Bruce W Patterson; Dominic N Reeds; Burton M Wice
Journal:  Peptides       Date:  2016-06-07       Impact factor: 3.750

7.  Xenin-25 increases cytosolic free calcium levels and acetylcholine release from a subset of myenteric neurons.

Authors:  Sheng Zhang; Krzysztof Hyrc; Songyan Wang; Burton M Wice
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-10-18       Impact factor: 4.052

8.  Global biochemical profiling identifies β-hydroxypyruvate as a potential mediator of type 2 diabetes in mice and humans.

Authors:  Sheng Zhang; Songyan Wang; Matthew D Puhl; Xuntian Jiang; Krzysztof L Hyrc; Erin Laciny; Michael J Wallendorf; Kirk L Pappan; Joseph T Coyle; Burton M Wice
Journal:  Diabetes       Date:  2014-11-03       Impact factor: 9.461

9.  Hormonal Responses to Cholinergic Input Are Different in Humans with and without Type 2 Diabetes Mellitus.

Authors:  Sara Chowdhury; Songyan Wang; Judit Dunai; Rachel Kilpatrick; Lauren Z Oestricker; Michael J Wallendorf; Bruce W Patterson; Dominic N Reeds; Burton M Wice
Journal:  PLoS One       Date:  2016-06-15       Impact factor: 3.240

10.  Cholinergic signaling mediates the effects of xenin-25 on secretion of pancreatic polypeptide but not insulin or glucagon in humans with impaired glucose tolerance.

Authors:  Songyan Wang; Lauren Z Oestricker; Michael J Wallendorf; Karin Sterl; Judit Dunai; C Rachel Kilpatrick; Bruce W Patterson; Dominic N Reeds; Burton M Wice
Journal:  PLoS One       Date:  2018-02-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.